Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BULK DEALS
Bulk Deals      
Biogen Pharmachem Industries Ltd.
BSE Code 531752
ISIN Demat INE703D01023
Book Value 1.10
NSE Code NA
Dividend Yield % 0.00
Market Cap 478.38
P/E 19.17
EPS 0.03
Face Value 1  
 
 
   
Deal DateCompany NameClient NameTranQty.(000's)ValuePriceTrade(Rs.in Lakhs)Close Price
10-Jul-2024 Biogen Pharmachem TOPGAIN FINANCE PRIVATE LIMITEDSELL 33550001.343615000.53
09-Jul-2024 Biogen Pharmachem TOPGAIN FINANCE PRIVATE LIMITEDBUY 44409011.446394897.440.53
09-Jul-2024 Biogen Pharmachem TOPGAIN FINANCE PRIVATE LIMITEDSELL 10859011.441563697.440.53
05-Jul-2024 Biogen Pharmachem JAI VINAYAK SECURITIESBUY 32746091.725632327.480.53
05-Jul-2024 Biogen Pharmachem JAI VINAYAK SECURITIESSELL 36200351.76154059.50.53
03-Jul-2024 Biogen Pharmachem SAHASTRAA ADVISORS PRIVATE LIMITEDBUY 37788391.234647971.970.53
03-Jul-2024 Biogen Pharmachem SAHASTRAA ADVISORS PRIVATE LIMITEDSELL 32916821.254114602.50.53
03-Jul-2024 Biogen Pharmachem TOPGAIN FINANCE PRIVATE LIMITEDBUY 37808321.234650423.360.53
03-Jul-2024 Biogen Pharmachem TOPGAIN FINANCE PRIVATE LIMITEDSELL 37808321.234650423.360.53
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.